Literature DB >> 22215711

Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

Elizabeth S Muxfeldt1, Roberto Fiszman, Fabio de Souza, Bianca Viegas, Fernanda C Oliveira, Gil F Salles.   

Abstract

Resistant hypertension is defined as uncontrolled office blood pressure, despite the use of ≥3 antihypertensive drugs. Ambulatory blood pressure monitoring (ABPM) is mandatory to diagnose 2 different groups, those with true and white-coat resistant hypertension. Patients are found to change categories between controlled/uncontrolled ambulatory pressures without changing their office blood pressures. In this way, ABPM should be periodically repeated. The aim of this study was to evaluate the most appropriate time interval to repeat ABPM to assure sustained blood pressure control in patients with white-coat resistant hypertension. This prospective study enrolled 198 patients (69% women; mean age: 68.9±9.9 years) diagnosed as white-coat resistant hypertension on ABPM. Patients were submitted to a second confirmatory examination 3 months later and repeated twice at 6-month intervals. Statistical analyses included Bland-Altman repeatability coefficients and multivariate logistic regression. Mean office blood pressure was 163±20/84±17 mm Hg, and mean 24-hour blood pressure was 118±8/66±7 mm Hg. White-coat resistant hypertension diagnosis presented a moderate reproducibility and was confirmed in 144 patients after 3 months. In the third and fourth ABPMs, 74% and 79% of patients sustained the diagnosis. In multivariate regression, a daytime systolic blood pressure ≤115 mm Hg in the confirmatory ABPM triplicated the chance of white-coat resistant hypertension status persistence after 1 year. In conclusion, a confirmatory ABPM is necessary after 3 months of the first white-coat-resistant hypertension diagnosis, and the procedure should be repeated at 6-month intervals, except in patients with daytime systolic blood pressure ≤115 mm Hg, in whom it may be repeated annually.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215711     DOI: 10.1161/HYPERTENSIONAHA.111.185405

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Authors:  Antonios A Lazaridis; Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

2.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

3.  Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Authors:  Paul E Drawz; Nicholas M Pajewski; Jeffrey T Bates; Natalie A Bello; William C Cushman; Jamie P Dwyer; Lawrence J Fine; David C Goff; William E Haley; Marie Krousel-Wood; Andrew McWilliams; Dena E Rifkin; Yelena Slinin; Addison Taylor; Raymond Townsend; Barry Wall; Jackson T Wright; Mahboob Rahman
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

Review 4.  Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters?

Authors:  Claudia R L Cardoso; Gil F Salles
Journal:  Curr Hypertens Rep       Date:  2016-12       Impact factor: 5.369

5.  Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.

Authors:  Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2014-10-02

Review 6.  Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.

Authors:  A Oliveras; A de la Sierra
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

Review 7.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

8.  Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring.

Authors:  Audes D M Feitosa; Marco A Mota-Gomes; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Rodrigo P Pedrosa; Paula C Oliveira; Camila L D M Feitosa; Andréa A Brandão; José L Lima-Filho; Andrei C Sposito; Antonio Coca; Wilson Nadruz
Journal:  Hypertens Res       Date:  2019-07-02       Impact factor: 3.872

Review 9.  Treatment of Resistant and Refractory Hypertension.

Authors:  Maria Czarina Acelajado; Zachary H Hughes; Suzanne Oparil; David A Calhoun
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

10.  Reliability of morning, before-dinner, and at-bedtime home blood pressure measurements in patients with hypertension.

Authors:  Takeshi Fujiwara; Satoshi Hoshide; Hiroshi Kanegae; Masafumi Nishizawa; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.